Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Bahekar

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Drug Research|July 10, 2020
Combination of Lorcaserin and GLP-1/glucagon Coagonist Improves Metabolic Dysfunction in Diet Induced-obese MiceVishal Patel, Amit Joharapurkar, Samadhan Kshirsagar, et al.
Pharmacological Reports : PR|May 15, 2012
Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effectNirav Dhanesha, Amit Joharapurkar, Gaurang Shah, et al.
Journal of Diabetes|February 24, 2012
Exendin-4 ameliorates diabetic symptoms through activation of glucokinaseNirav Dhanesha, Amit Joharapurkar, Gaurang Shah, et al.
European Journal of Pharmacology|July 2, 2013
Treatment with exendin-4 improves the antidiabetic efficacy and reverses hepatic steatosis in glucokinase activator treated db/db miceNirav Dhanesha, Amit Joharapurkar, Gaurang Shah, et al.
Canadian Journal of Physiology and Pharmacology|December 3, 2013
Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 miceVishal Patel, Amit Joharapurkar, Nirav Dhanesha, et al.
Canadian Journal of Physiology and Pharmacology|December 3, 2015
Central GLP-1 receptor activation improves cholesterol metabolism partially independent of its effect on food intakeVishal Patel, Amit Arvind Joharapurkar, Samadhan Govind Kshirsagar, et al.
Biomedical Chromatography : BMC|April 4, 2017
Sensitive and specific LC-ESI-MS/MS method for determination of ZYDPLA1, a novel long-acting dipeptidyl peptidase 4 inhibitor in rat plasma: An application for toxicokinetic study in ratsPoonam Giri, Nirmal Patel, Bharat Patel, et al.
Canadian Journal of Physiology and Pharmacology|November 1, 2014
Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese miceKartikkumar Navinchandra Patel, Amit Arvind Joharapurkar, Vishal Patel, et al.
Pharmacological Reports : PR|October 23, 2013
Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic miceVishal Patel, Amit Joharapurkar, Nirav Dhanesha, et al.
Journal of Diabetes|July 27, 2012
Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (-4 db/db)*Vishal Patel, Amit Joharapurkar, Tejal Gandhi, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Drug Research|July 10, 2020
Combination of Lorcaserin and GLP-1/glucagon Coagonist Improves Metabolic Dysfunction in Diet Induced-obese MiceVishal Patel, Amit Joharapurkar, Samadhan Kshirsagar, et al.
Pharmacological Reports : PR|May 15, 2012
Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effectNirav Dhanesha, Amit Joharapurkar, Gaurang Shah, et al.
Journal of Diabetes|February 24, 2012
Exendin-4 ameliorates diabetic symptoms through activation of glucokinaseNirav Dhanesha, Amit Joharapurkar, Gaurang Shah, et al.
European Journal of Pharmacology|July 2, 2013
Treatment with exendin-4 improves the antidiabetic efficacy and reverses hepatic steatosis in glucokinase activator treated db/db miceNirav Dhanesha, Amit Joharapurkar, Gaurang Shah, et al.
Canadian Journal of Physiology and Pharmacology|December 3, 2013
Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 miceVishal Patel, Amit Joharapurkar, Nirav Dhanesha, et al.
Canadian Journal of Physiology and Pharmacology|December 3, 2015
Central GLP-1 receptor activation improves cholesterol metabolism partially independent of its effect on food intakeVishal Patel, Amit Arvind Joharapurkar, Samadhan Govind Kshirsagar, et al.
Biomedical Chromatography : BMC|April 4, 2017
Sensitive and specific LC-ESI-MS/MS method for determination of ZYDPLA1, a novel long-acting dipeptidyl peptidase 4 inhibitor in rat plasma: An application for toxicokinetic study in ratsPoonam Giri, Nirmal Patel, Bharat Patel, et al.
Canadian Journal of Physiology and Pharmacology|November 1, 2014
Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese miceKartikkumar Navinchandra Patel, Amit Arvind Joharapurkar, Vishal Patel, et al.
Pharmacological Reports : PR|October 23, 2013
Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic miceVishal Patel, Amit Joharapurkar, Nirav Dhanesha, et al.
Journal of Diabetes|July 27, 2012
Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (-4 db/db)*Vishal Patel, Amit Joharapurkar, Tejal Gandhi, et al.
Pageof 4